Ceftaroline versus standard therapy for pneumococcal meningitis in critically ill patients

Med Intensiva (Engl Ed). 2022 Jun;46(6):348-350. doi: 10.1016/j.medine.2021.05.007.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Ceftaroline
  • Cephalosporins / therapeutic use
  • Critical Illness
  • Humans
  • Meningitis, Pneumococcal* / drug therapy

Substances

  • Anti-Bacterial Agents
  • Cephalosporins